Targeting tumor immunity with transferrin receptor-directed photodynamic therapy

This new article publication from Acta Pharmaceutica Sinica B, discusses a transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB interruption.

Novo declares Phase 3 cardiac outcomes trial win for oral GLP-1

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 22, 2024

Olive oil prevents weight gain while butter and margarine add pounds, study finds

A long-term study of 121,119 participants found that increasing olive oil intake was associated with less weight gain over time, while consuming margarine, butter, and

February 21, 2025

Roche begins Phase 2 obesity trial for GLP-1/GIP agonist, striking while iron is hot

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.